SAFE Act of 2022
Sponsored By: Representative Pappas, Chris [D-NH-1]
Unknown
Summary
Save Americans from the Fentanyl Emergency Act of 2022 or the SAFE Act of 2022 This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. It limits the application of mandatory minimum penalties for certain offenses involving fentanyl-related substances, establishes a process to deschedule or remove certain fentanyl-related substances that have a low potential for abuse, and allows a federal court to vacate or reduce the sentence for convictions of offenses involving a fentanyl-related substance that is descheduled or moved to a schedule other than schedule I or II. The bill establishes a new, alternative registration process for schedule I research. It also makes other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the bill requires the Government Accountability Office to analyze the implementation and impact of permanently placing fentanyl-related substances into schedule I of the Controlled Substances Act.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Pappas, Chris [D-NH-1]
NH • D
Cosponsors
Rep. Newhouse, Dan [R-WA-4]
WA • R
Sponsored 3/7/2022
Sen. Budd, Ted [R-NC]
NC • R
Sponsored 3/7/2022
Rep. Suozzi, Thomas R. [D-NY-3]
NY • D
Sponsored 3/8/2022
Rep. Van Drew, Jefferson [R-NJ-2]
NJ • R
Sponsored 3/8/2022
Rep. Cuellar, Henry [D-TX-28]
TX • D
Sponsored 3/8/2022
Rep. Roybal-Allard, Lucille [D-CA-40]
CA • D
Sponsored 3/8/2022
Rep. Craig, Angie [D-MN-2]
MN • D
Sponsored 3/15/2022
Rep. Spanberger, Abigail Davis [D-VA-7]
VA • D
Sponsored 3/15/2022
Rep. Gonzales, Tony [R-TX-23]
TX • R
Sponsored 4/4/2022
Rep. Bacon, Don [R-NE-2]
NE • R
Sponsored 7/14/2022
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov